Company news
Ardelyx, Inc. news in 2019
Ardelyx, Inc.'s news releases, calls and decks from 2019, newest first.
Ardelyx Announces Pricing of Upsized Public Offering of Common Stock
December 3, 2019
Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis
December 2, 2019
Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study
December 1, 2019
Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements
November 24, 2019
Ardelyx Announces Presentation at Kidney Week 2019
November 5, 2019
Ardelyx Announces Positive Results from the Pivotal Phase 3 AMPLIFY Study Evaluating Tenapanor in Dialysis Patients Who Have Uncontrolled Hyperphosphatemia Despite Phosphate Binder Treatment
September 2, 2019
Ardelyx Reports Second Quarter 2019 Financial Results and Recent Business Highlights
August 8, 2019
Decks in 2019
- Corporate Update (December 2019)
Corporate update · 22 slides · Dec 3, 2019
- J.P. Morgan Healthcare Conference 2019
Conference · 20 slides · Jan 7, 2019